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Abstract
M-CSF is a growth factor that stimulates proliferation and differentiation of monocyte/macrophage-lineage cells. In our
previous studies, M-CSF regresses atherosclerotic lesions preformed in aorta of high cholesterol-fed rabbit. Immunohis-
tochemical analysis indicated that extracellular matrix (ECM), such as collagen, was especially eliminated in the intima of
atherosclerotic lesion. To define the collagen-lowering potential of M-CSF, we have studied the effects of M-CSF on
production of collagen-degrading proteases, such as MMP-1, -9 and urokinase in vitro. Monocytes freshly isolated from
human peripheral blood produced MMP-9, but not urokinase, and M-CSF enhanced MMP-9 production. Macrophages
were prepared by culturing monocytes for 10 days in the presence or absence of M-CSF, and protease production was
assayed. M-CSF augmented production of MMP-9 and urokinase in a dose-dependent manner. M-CSF also enhanced
MMP-1 production of macrophages, but not significantly. Foam cells were prepared by culturing macrophages in the
presence of acetyl LDL, and protease production from these cells were also elevated by M-CSF. These results suggest that
M-CSF exogenously administered in atherosclerotic rabbits might regress the thickened intima by activating macrophages to
degrade collagen accumulated in the lesion. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
M-CSF is produced by variety of cell types includ-
ing macrophage, endothelial cell, ¢broblast and lym-
phocyte [1^4]. In recent studies, local production of
M-CSF and its gene expression have been detected
during atherogenesis [7,8], suggesting that M-CSF
may play an important role in the atherosclerotic
lesions. Serum cholesterol-lowering activity of M-
CSF was at ¢rst found in a clinical trial concerning
chronic neuropenia boys [9], and has been also ex-
perimentally demonstrated using rabbits and non-hu-
man primates [10^12]. Additional studies have shown
that M-CSF enhances the clearance of lipoproteins
and modi¢ed lipoproteins through LDL receptor and
scavenger receptor [10,13], and that M-CSF enhances
cholesterol metabolism by upregulation of activities
of neutral cholesteryl ester hydrolase (CEH) and
acidic CEH and acyl CoA cholesterol acyltransferase
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[14]. M-CSF also stimulates secretion of apo E and
retroendocytosis of cholesterol ester by HDL-de-
pendent processes [15]. Anti-atherosclerotic e¡ects
of M-CSF were demonstrated by repeated injection
of M-CSF into Watanabe heritable hyperlipidemic
(WHHL) rabbits, resulting in prevention of athero-
sclerosis progression [10,16].
In our early study, administration of M-CSF led
to the regression of atherosclerotic lesion which was
preformed in high cholesterol diet rabbits [17]. In this
paper, we performed immunohistochemical analyses
on the intima of atherosclerotic lesion of these rab-
bits. Furthermore, we investigated in vitro e¡ects of
M-CSF on protease production from monocyte,
macrophage and foam cell which might degrade
ECM accumulated in atherosclerotic lesion. We as-
sayed type I collagenase (MMP-1), gelatinase (MMP-
9) and urokinase that degrades ECM and activates
MMPs through activation of plasmin [18,19], and
found that M-CSF augments protease production
from monocyte, macrophage and foam cell.
2. Materials and methods
2.1. M-CSF
Recombinant human M-CSF (Genetics Institute,
Cambridge, MA) was puri¢ed from culture superna-
tants of Chinese hamster ovary (CHO) cells trans-
fected with cDNA of human M-CSF. This prepara-
tion showed a speci¢c activity of 4U108 U/mg
protein by colony formation assay with mouse
bone marrow cells, and had endotoxin of less than
10 pg/105 U/ml by Limlus assay (Seikagakukogyo,
Tokyo).
2.2. In vivo studies
Twelve-week-old male New Zealand white rabbits
(2.4^3.0 kg, Kitayama, Kyoto) were fed with 2.0%
cholesterol for 8 weeks. Then the rabbits were taken
normal diet, and 80 Wg/kg of M-CSF or human se-
rum albumin (HSA), as a control, was intramuscu-
larly administered once a day for another 12 weeks.
Animals were sacri¢ced under anesthesia with thio-
pentalsodium. The aorta from arch to abdominal
region was excised and cut to open lengthwise.
2.3. Immunohistochemistry
The aortic strip was ¢xed in PBS containing 1%
formalin for more than 12 h at 4‡C. Then the speci-
mens were embedded in para⁄n, and immunostained
with anti-collagen I^V polyclonal antibody (Sanbio,
Netherlands) using streptoavidin-biotin method (His-
to¢ne SAB-PO (R) kit, Nichirei, Tokyo). Collagen
was identi¢ed as light-brown color by immunohisto-
chemical staining. The immunostained specimens
were projected onto a microcomputer imaging device
(Luzex IID, Nireco, Tokyo) to measure collagen-pos-
itive area.
2.4. Cells
Human peripheral blood was obtained from
healthy volunteers who gave informed consent. Us-
ing Percoll density gradient centrifugation, mono-
cytes were prepared from mononuclear cells that
were prepared from blood by Ficoll-Paque density
gradient centrifugation [20].
2.5. Cell culture
Monocytes were suspended in 1:1 (v/v) mixture of
Ham’s F-12/Dulbecco’s modi¢ed eagle’s medium
(Nissui, Tokyo) supplemented with 10% human se-
rum (Type AB, Sigma, St. Louis, MO), and cultured
for 2 days in the presence or absence of M-CSF.
Culture supernatants were harvested, and stored at
380‡C until assays. Macrophages were prepared by
cultivation for 10 days in the media described above,
C
Fig. 1. Collagens decrease in aorta of atherogenic rabbits by treatment with M-CSF. Rabbits were fed with 2.0% cholesterol diet for
8 weeks, and followed by treatment with 80 Wg/kg of M-CSF (a) or HSA (b) by intramuscularly administration once a day for anoth-
er 12 weeks. Collagens accumulated in atherogenic aorta were stained with anti-collagen I^V polyclonal antibody (U39). Treatment
with M-CSF diminished the thickened intima (upper half of the specimens), and decreased collagen content. Similar results were ob-
tained from ten (M-CSF) and seven (HSA) rabbits.
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which were changed every 3^4 days, and cultured for
an additional 2 days in medium without M-CSF and
serum. Foam cells were prepared by culturing macro-
phages with 100 Wg/ml of acetyl LDL for 2 days in
medium without serum. Each culture supernatant
was collected, and stored at 380‡C.
2.6. Assays
Cellular DNA was measured by the method of
Labarca et al. [21]. MMP-1 was measured by degra-
dation of FITC-labeled type I collagen after activa-
tion by trypsin (Yagai, Yamagata, Japan). MMP-9
was assayed by gelatin zymography as described pre-
viously [22]. Sample of each lane was adjusted the
volume to same quantity of cellular DNA. Urokinase
was assayed by ELISA (Biopool, Sweden).
2.7. Oil red O stain
Foam cells were ¢xed in 10% formalin for 5 min,
and washed in water. Cells were treated with 60%
isopropanol for 1 min, and then stained for 15 min
at 37‡C with 0.18% oil red O in 60% isopropanol.
After washing in 60% isopropanol and water, cells
were counter-stained with Hematoxylin for 5 min.
2.8. Statistics
Paired t-test was used to determine the signi¢cance
of di¡erences. A P-value of 6 0.05 was considered as
statistically signi¢cant, but most of the signi¢cant
values were at least P6 0.01.
3. Results
3.1. E¡ect of M-CSF on atherosclerotic lesions in
aorta of cholesterol-fed rabbits
From our previous studies, M-CSF reduced athe-
rosclerotic lesion in cholesterol-fed rabbits by activa-
tion of reverse cholesterol transport. Furthermore,
we analyzed atherogenic aorta of these rabbits by
immunohistochemical staining. Collagen was accu-
mulated in the intimal lesion of control rabbits,
and 45% of thickened intima was collagen positive
(Fig. 1b, n = 7). In contrast, the collagen-positive
area in the intima decreased to 29% by M-CSF-treat-
ment (Fig. 1a, n = 10). Because intimal thickness of
M-CSF-treated rabbits was half as much as that of
control rabbits, M-CSF reduced 63% of collagen in
the aorta of atherosclerotic lesion. Thus, the e¡ect of
M-CSF on atherosclerotic lesion is not only simple
regression of the thickness of intima of aorta, but
also reduction of collagen positive ratio. From these
results, we presumed that M-CSF accelerates degra-
dation of collagens, and studied e¡ects of M-CSF on
protease production from monocyte, macrophage
and foam cell.
3.2. E¡ect of M-CSF on protease production of
monocytes
Peripheral blood monocytes from six di¡erent do-
nors were cultured in 10% human serum containing
medium with or without 104 U/ml of M-CSF for
2 days, and proteases in the supernatants were meas-
ured. Sample of each lane was adjusted the volume
to same quantity of cellular DNA. Monocytes iso-
lated from all tested donors produced MMP-9, which
was identi¢ed as clear bands at molecular weight of
92 kDa in zymograms, and M-CSF enhanced MMP-
9 production of monocytes (Fig. 2). Activated form
of MMP-9 with molecular weight of 83 kDa [23] was
detected as a minor band, but MMP-2, another ge-
latinase with molecular weight of 72 kDa [24,25] was
not detected in the zymograms. Urokinase was not
detected (6 4.3 pg/Wg DNA). MMP-1 activity could
not be detected probably because of inhibitor(s) in-
cluded in human serum [26,27].
3.3. E¡ect of M-CSF on protease production of
macrophages
Macrophages were prepared by culturing mono-
cytes for 10 days in the presence or absence of 104
U/ml of M-CSF. Media were replaced by those of
serum free, and cells were cultured for additional
2 days. MMP-1, MMP-9 and urokinase produced
in the supernatants were measured. Since M-CSF
supported cellular survival during cultivation in vitro
(Fig. 3), cell numbers were estimated as DNA
amounts, and protease productivity was normalized.
Macrophage produced these enzymes, and produc-
tion of MMP-9 and urokinase was elevated during
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cellular di¡erentiation from monocyte to macro-
phage in vitro (Figs. 2 and 4). M-CSF-treated macro-
phages obtained from ¢ve donors produced higher
amounts of these proteases than control cells (Fig.
4), although the e¡ect of M-CSF on MMP-1 produc-
tion was not signi¢cant (Ps 0.05). The production of
active form MMP-9 (83 kDa) was elevated by
M-CSF in parallel with that of inactive form (92
kDa). The active form of MMP-1, which was iden-
ti¢ed as collagenolytic activity without activation by
trypsin, was not detected in the culture supernatants
whichever M-CSF was added or not (data not
shown).
3.4. E¡ect of M-CSF on protease production of foam
cells
Foam cells were prepared by culturing macro-
phages in serum-free medium containing 100 Wg/ml
of acetyl LDL for 2 days. These cells looked gran-
ulous, and clearly stained with oil red O, indicating
that these cells were foam cells. The pattern and in-
tensity of oil red O staining were not di¡erent be-
tween M-CSF-treated and control foam cells (data
not shown). Proteases in the culture supernatants
were assayed (Fig. 4). The productivity of these pro-
teases was not di¡erent between macrophages and
foam cells (Fig. 4), and M-CSF enhanced protease
production from foam cells as well as from macro-
phages.
3.5. Dose e¡ect of M-CSF on survival and protease
production of macrophages
Monocytes were cultured for 10 days with M-CSF
at concentrations of 0, 102, 103, 104 and 105 U/ml,
and further cultured in serum-free media for 2 days.
M-CSF at more than 103 U/ml supported cellular
Fig. 3. M-CSF supports survival and proliferation of mono-
cytes. Monocytes of six donors were cultured in the presence of
M-CSF at concentrations of 0, 102, 103, 104, 105 U/ml. After
10 days, DNA contents were measured. P6 0.01; compared
with M-CSF-untreated control.
Fig. 2. M-CSF enhances MMP-9 production of monocytes. Monocytes of six donors were cultured with or without 104 U/ml of M-
CSF. After 2 days, activity of MMP-9 in the culture supernatants was measured by gelatin zymography. Sample of each lane was ad-
justed the volume to same quantity of cellular DNA.
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Fig. 4. E¡ect of M-CSF on protease production of macrophage and foam cell. Macrophages were obtained by culture of monocytes
for 10 days with or without 104 U/ml of M-CSF, and cultured for another 2 days in serum free medium with or without 100 Wg/ml
of acetyl-LDL. MMP-1 (a), UK (b) and MMP-9 (c) in the supernatants were assayed. P6 0.05; compared with M-CSF-untreated
control.
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Fig. 5. Dose^response of M-CSF on protease production of macrophage. Macrophages were obtained by culture of monocytes for
10 days with 0^105 U/ml of M-CSF, and cultured for another 2 days. MMP-1 (a) and UK (b) in the supernatants were assayed.
MMP-9 (c) produced from cells of equal DNA amounts were analyzed by gelatin zymography. Culture supernatants of macrophage
treated with M-CSF at the concentrations of 0 (lane c), 102 (lane 2), 103 (lane 3), 104 (lane 4), 105 (lane 5) U/ml of M-CSF were ex-
amined. P6 0.01; compared with M-CSF-untreated control.
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survival signi¢cantly (Fig. 3). M-CSF at more than
103 U/ml also enhanced MMP-9 and urokinase pro-
duction from macrophages (Fig. 5b,c). MMP-1 pro-
duction of macrophages prepared from several do-
nors was elevated by M-CSF, although e¡ect of M-
CSF on MMP-1 production was not signi¢cant (Fig.
5a). These results indicated that M-CSF supports
monocyte/macrophage survival, and enhances pro-
tease production in a dose-dependent manner, which
might degrade collagens and other ECMs accumu-
lated in atherosclerotic lesion.
4. Discussion
M-CSF is known as a glycoprotein which stimu-
lates the proliferation and the di¡erentiation of
monocytes/macrophages [5,6]. Recent studies sug-
gested that M-CSF might play an important role in
atherosclerosis [7^16]. Macrophage is one of the ma-
jor cell types in atherosclerotic lesion [7,8,28]. Ad-
ministration of M-CSF led to the reduction in plas-
ma cholesterol [8^13] and the prevention of
atherosclerosis progression in WHHL rabbits [16].
These e¡ects of M-CSF have been explained due to
the regulation of cholesterol metabolism by increas-
ing the number of LDL receptor and scavenger re-
ceptor [10,13] and by up-regulation of neutral and
acidic CEH [14]. In our previous study, we demon-
strated that M-CSF promotes the regression of athe-
rosclerosis which has been made in rabbits by high
cholesterol diet (2%) for 8 weeks [17]. Intramuscular
administration of M-CSF at 80 Wg/kg/day for 12
weeks halved the mean intimal thickness of aortic
arch, when compared with that of HSA-injected
(0.34 vs. 0.60 mm, respectively). Immunohistochem-
ical analysis revealed that one of the most remark-
able e¡ect of M-CSF on the atherosclerotic lesion is
the reduction of the area positively stained for colla-
gen type I^V (Fig. 1). Since cells of monocyte/macro-
phage-lineage produce proteases that degrade colla-
gens [29^39], we investigated e¡ects of M-CSF on
protease production from monocyte, macrophage
and foam cell. Rouis et al. reported that acetyl
LDL induces proteases from macrophages [40], and
that M-CSF enhances scavenger receptor expression
and uptake of modi¢ed LDL [10,13]. Thus, we at
¢rst speculated that M-CSF may enhance the pro-
tease production induced by acetyl LDL. However,
our data suggests that M-CSF enhances protease
production by itself, and that MMP-1, MMP-9 and
urokinase production from macrophage is not af-
fected by acetyl LDL. A elastinolytic metalloprotease
induced by acetyl LDL, which is reported by Rouis
et al. [39], is not MMP-9, but might be other pro-
tease like MMP-3, which shows less elastinolytic ac-
tivity than MMP-9 [24,25]. Our results that foam
cells produced similar amounts of urokinase as mac-
rophages did might con£ict with those of others who
reported that acetyl LDL induces urokinase produc-
tion from murine macrophages [41,42]. The discrep-
ancy is not understood, but M-CSF is also a potent
inducer of urokinase from macrophages [43^45] as
we observed in this paper, and M-CSF is produced
during cultivation in vitro [46^48]. Thus, it may be
possible that urokinase was induced by endogenous
M-CSF, which overcame the urokinase induction by
acetyl LDL. It is also thought that the discrepancy
may be due to the di¡erence between murine and
human macrophage.
In this paper, we studied the e¡ect of M-CSF on
atherosclerosis in terms of protease production of
monocyte, macrophage and foam cell. Macrophage
has been found to produce various MMPs, such as
interstitial collagenase (MMP-1), 92-kDa gelatinize
(MMP-9) and stromelysin (MMP-3). These MMPs
are produced as inactive precursors that are activated
by plasmin and or by MMPs. [18,19]. MMP-3 can
activate MMP-1 and MMP-9, and plasmin is also
able to activate these pro-enzymes in atherosclerotic
lesion. Because plasminogen exists in the lesion [49],
urokinase produced by macrophage is thought to be
able to activate MMP precursors indirectly.
From our results, a possible mechanism of M-CSF
anti-atherosclerotic e¡ect is thought as follows. Pro-
duction of MMP-9 is increased during di¡erentiation
from monocytes to macrophages, and enhanced by
M-CSF. As MMP-9 is known as protease which is
active in tissue invasion [50,51], MMP-9 might play
an important role in atherosclerosis trans-endothelial
migration of monocyte to atherosclerotic lesions. In
intimal lesion, macrophage and foam cell produce
MMP-1, MMP-9 as well as urokinase that can acti-
vates MMP precursors. M-CSF enhances this pro-
tease production, and might activate degradation of
collagens accumulated there. Moreover, M-CSF sup-
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ports macrophage survival [52,53] and may rescue
foam cell from apoptotic cell death. In conclusion,
it might be possible that the e¡ects of M-CSF on
atherosclerosis are due not only to enhancement of
cholesterol metabolism, but also to enhancement of
protease production.
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